干预细胞因子信号传递:牛皮治疗的新视野
Lisha Li1,2,3, Jun Liu1,2, Jiaye Lu1,2
1Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China.
Frontiers in immunology
|April 30, 2025
概括
牛皮的发病包括复杂的免疫细胞和细胞因子相互作用. 针对IL-17,IL-23和TNF-α等特定细胞因子,为这种慢性炎症性皮肤疾病提供了有前途的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
背景情况:
- 牛皮是一种免疫介导的慢性炎症性皮肤疾病.
- 细胞因子 (干细胞因子,干扰素,TNF-α,化学因子) 是免疫反应和恒温的关键调节者.
- 这些信号分子极大地影响了牛皮病原和治疗反应.
研究的目的:
- 审查当前关于皮病中细胞因子和化学因子信号传递的知识.
- 检查针对这些途径的治疗潜力.
- 为突出针对牛皮的向治疗方法的进展.
主要方法:
- 对皮病中细胞因子和化学因子通路的最近研究的文献综述.
- 分析特定细胞因子 (IL-17,IL-23,TNF-α) 在疾病病理学中的作用.
- 检查新兴的向疗法,包括单克隆抗体.
主要成果:
- 细胞因子在牛皮的病理过程中发挥着中心作用.
- 向细胞因子和化学因子提供了新的治疗途径.
- 像IL-17,IL-23和TNF-α这样的特定细胞因子是关键的治疗点.
结论:
- 调节细胞因子和化学因子通路对于治疗牛皮至关重要.
- 有针对性的疗法,特别是单克隆抗体,显示出显著的前景.
- 需要进一步的研究来优化牛皮管理的创新疗法.
相关概念视频
The JAK-STAT Signaling Pathway
8.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.4K
T Cell Types and Functions
615
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
615
Inflammatory Response
1.6K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.6K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
97
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
97
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Inflammatory Bowel Disease IV: Pharmacological Management
79
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
79


